• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[十年国家研究项目“家族性前列腺癌”:识别高危家族中的问题]

[Ten years national research project "familial prostate cancer": problems in identifying risk families].

作者信息

Herkommer K, Schmidt C, Gschwend J E

机构信息

Urologische Klinik, Klinikum rechts der Isar der TU München, Ismaningerstraße 22, 81675 München, Deutschland.

出版信息

Urologe A. 2011 Jul;50(7):813-20. doi: 10.1007/s00120-011-2552-4.

DOI:10.1007/s00120-011-2552-4
PMID:21461841
Abstract

BACKGROUND

The German national research project"familial prostate cancer" has been recruiting prostate cancer patients nationwide since 1999. In 2009, a comprehensive data analysis of the 25,065 families recruited was performed. Of these, 77.4% were identified as sporadic, 20.0% as familial and 2.6% as hereditary cases of prostate cancer. However, obtaining comprehensive, validated information about all relatives often fails.

RESULTS

The high average age of the patients, the lower life expectancy in further generations and the low number of first-degree male relatives hampers the classification of sporadic, familial and hereditary cases. Consequently we describe here that in our database the identification of 100 hereditary cases requires a recruitment of more than 5,000 patients with their families. For 100 sporadic patients with 2 first-degree male relatives without a case history 1,250 patients are needed.

摘要

背景

德国国家研究项目“家族性前列腺癌”自1999年起在全国范围内招募前列腺癌患者。2009年,对招募的25065个家庭进行了全面的数据分析。其中,77.4%被确定为散发性,20.0%为家族性,2.6%为遗传性前列腺癌病例。然而,获取所有亲属的全面、经过验证的信息往往难以实现。

结果

患者的平均年龄较高、后代预期寿命较低以及一级男性亲属数量较少,阻碍了散发性、家族性和遗传性病例的分类。因此,我们在此描述,在我们的数据库中,识别100例遗传性病例需要招募超过5000名患者及其家属。对于100例有2名无病史的一级男性亲属的散发性患者,需要1250名患者。

相似文献

1
[Ten years national research project "familial prostate cancer": problems in identifying risk families].[十年国家研究项目“家族性前列腺癌”:识别高危家族中的问题]
Urologe A. 2011 Jul;50(7):813-20. doi: 10.1007/s00120-011-2552-4.
2
[Association of a positive family history with histopathology and clinical course in early-onset prostate cancer].[早发性前列腺癌的家族史阳性与组织病理学及临床病程的关联]
Urologe A. 2006 Dec;45(12):1532-9. doi: 10.1007/s00120-006-1190-8.
3
Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.耻骨后根治性前列腺切除术后家族性和遗传性前列腺癌对癌症特异性生存的影响。
J Urol. 2006 Sep;176(3):1118-21. doi: 10.1016/j.juro.2006.04.077.
4
[Preventing prostate carcinoma in men with familial disposition].
Urologe A. 2002 Nov;41(6):596-601. doi: 10.1007/s00120-002-0190-6.
5
[Epidemiology of familial prostatic cancer: 4-year assessment of French studies].[家族性前列腺癌的流行病学:法国研究的4年评估]
Prog Urol. 1999 Sep;9(4):672-9.
6
Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.高危家族中前列腺癌的靶向筛查:早发是一级亲属患该病的重要风险因素。
J Urol. 2002 Aug;168(2):483-7. doi: 10.1016/s0022-5347(05)64663-0.
7
Association between the clinical presentation and epidemiological features of familial prostate cancer in patients selected for radical prostatectomy.
Eur Urol. 2003 Jun;43(6):615-21. doi: 10.1016/s0302-2838(03)00146-5.
8
[Familial prostate carcinoma in Germany].
Urologe A. 2002 Jan;41(1):38-43. doi: 10.1007/s120-002-8229-2.
9
[Familial versus sporadic prostate cancer in the German population. Clinical and pathological characteristics in patients after radical prostatectomy].
Urologe A. 2003 Jul;42(7):946-53. doi: 10.1007/s00120-003-0296-5. Epub 2003 Mar 14.
10
Familial risk and familial survival in prostate cancer.前列腺癌的家族风险和家族生存。
World J Urol. 2012 Apr;30(2):143-8. doi: 10.1007/s00345-011-0801-1. Epub 2011 Nov 25.

引用本文的文献

1
[Familial prostate cancer and genetic predisposition].[家族性前列腺癌与遗传易感性]
Urologe A. 2021 May;60(5):567-575. doi: 10.1007/s00120-021-01491-y. Epub 2021 Mar 15.
2
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy.有前列腺癌家族史的男性在根治性前列腺切除术后疾病复发的风险更高。
World J Urol. 2018 Feb;36(2):177-185. doi: 10.1007/s00345-017-2122-5. Epub 2017 Nov 21.
3
[Familial prostate cancer research: meaningfulness of hereditary criteria in view of demographic change].

本文引用的文献

1
Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies.利用来自英国和澳大利亚基于人群的研究的 4390 个家族进行前列腺癌分离分析。
Genet Epidemiol. 2010 Jan;34(1):42-50. doi: 10.1002/gepi.20433.
2
How common is familial cancer?家族性癌症有多常见?
Ann Oncol. 2008 Jan;19(1):163-7. doi: 10.1093/annonc/mdm414. Epub 2007 Sep 5.
3
[Association of a positive family history with histopathology and clinical course in early-onset prostate cancer].[早发性前列腺癌的家族史阳性与组织病理学及临床病程的关联]
[家族性前列腺癌研究:鉴于人口结构变化,遗传标准的意义]
Urologe A. 2014 Dec;53(12):1779-85. doi: 10.1007/s00120-014-3617-y.
4
Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors.家族史对前列腺癌幸存者心理社会困扰及治疗需求认知的影响。
Fam Cancer. 2014 Sep;13(3):481-8. doi: 10.1007/s10689-014-9715-6.
Urologe A. 2006 Dec;45(12):1532-9. doi: 10.1007/s00120-006-1190-8.
4
Germline mutations of the MSR1 gene in prostate cancer families from Germany.德国前列腺癌家族中MSR1基因的种系突变。
Hum Mutat. 2006 Jan;27(1):98-102. doi: 10.1002/humu.20271.
5
Population-based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases.遗传性前列腺癌(HPC)病例亲属中其他癌症的基于人群的风险评估。
Prostate. 2005 Sep 1;64(4):347-55. doi: 10.1002/pros.20248.
6
Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.RNASEL作为前列腺癌易感基因的突变筛查及关联研究。
Br J Cancer. 2005 Mar 28;92(6):1159-64. doi: 10.1038/sj.bjc.6602401.
7
Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis.有亲属患前列腺癌的男性患前列腺癌的相对风险:系统评价和荟萃分析。
Int J Cancer. 2003 Dec 10;107(5):797-803. doi: 10.1002/ijc.11466.
8
A systematic review and meta-analysis of familial prostate cancer risk.家族性前列腺癌风险的系统评价与荟萃分析。
BJU Int. 2003 Jun;91(9):789-94. doi: 10.1046/j.1464-410x.2003.04232.x.
9
Genetic fieldwork for hereditary prostate cancer studies.遗传性前列腺癌研究的基因实地调查。
Urol Oncol. 2002 Jan-Feb;7(1):19-27. doi: 10.1016/s1078-1439(01)00132-6.
10
Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.对1476个受前列腺癌影响的澳大利亚家庭进行分离分析。
Am J Hum Genet. 2001 May;68(5):1207-18. doi: 10.1086/320114. Epub 2001 Apr 11.